BRAIN and NERVE Shinkei Kenkyu no Shinpo Volume 69, Issue 10 (October 2017)
Japanese

Biomarkers for Mood Disorders and a Novel Antidepressant (R)-ketamine Kenji Hashimoto 1 1Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health Keyword: うつ病 , 双極性障害 , バイオマーカー , 抗うつ作用 , (R)-ケタミン , depression , bipolar disorder , biomarker , antidepressant , (R)-ketamine pp.1143-1148
Published Date 2017/10/1
DOI https://doi.org/10.11477/mf.1416200882
  • Abstract
  • Look Inside
  • Reference

Abstract

Depression is often misdiagnosed as major depressive disorder in patients with bipolar disorder. Therapeutic drugs for these two disorders are quite different, but the anesthetic ketamine shows fast-acting antidepressant effects in treatment-resistant patients with these disorders. Here, we discuss biomarkers for both disorders, recent findings regarding ketamine, and predictable biomarkers for ketamine's antidepressant actions.


Copyright © 2017, Igaku-Shoin Ltd. All rights reserved.

基本情報

18816096.69.10.jpg
BRAIN and NERVE-神経研究の進歩
69巻10号 (2017年10月)
電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有